n-cyclopropyl adenosine-5'-carboxamide has been researched along with 2-chloro-n(6)cyclopentyladenosine in 1 studies
Studies (n-cyclopropyl adenosine-5'-carboxamide) | Trials (n-cyclopropyl adenosine-5'-carboxamide) | Recent Studies (post-2010) (n-cyclopropyl adenosine-5'-carboxamide) | Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) |
---|---|---|---|---|---|
14 | 0 | 5 | 252 | 0 | 43 |
Protein | Taxonomy | n-cyclopropyl adenosine-5'-carboxamide (IC50) | 2-chloro-n(6)cyclopentyladenosine (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 0.0112 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0009 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auchampach, JA; Bitant, A; Ciancetta, A; Cui, Z; Gao, ZG; Gavrilova, O; Jacobson, KA; Lieberman, DI; Liu, N; Mannes, P; Mattison, JA; Rao, H; Reitman, ML; Rothwell, AC; Salmaso, V; Tosh, DK; Vaughan, KL | 1 |
1 other study(ies) available for n-cyclopropyl adenosine-5'-carboxamide and 2-chloro-n(6)cyclopentyladenosine
Article | Year |
---|---|
Design and in Vivo Characterization of A
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Bridged Bicyclo Compounds; CHO Cells; Cricetulus; Drug Design; HEK293 Cells; Humans; Macaca fascicularis; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Structure; Receptor, Adenosine A1; Structure-Activity Relationship | 2019 |